You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 8,669,273


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,669,273 protect, and when does it expire?

Patent 8,669,273 protects NERLYNX and is included in one NDA.

This patent has thirty-seven patent family members in twenty-five countries.

Summary for Patent: 8,669,273
Title:Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
Abstract: A combination of a 4-anilino-3-cyanoquinoline compound (e.g. HKI-272, SKI-606, EKB-569) and a capecitabine compound in the treatment of a neoplasm is provided. Regimens, kits, and methods for treatment of neoplasm, including breast cancer including metastatic breast cancer, and lung cancer, using this combination, optionally in combination with other anti-neoplastic agents, or immune modulators are also described.
Inventor(s): Zacharchuk; Charles Michael (Westford, MA), Quinn; Susan Elizabeth (Norwood, MA), Wang; Kenneth Kuan-Yuen (Waltham, MA), Binlich; Florence Marie Helene (Ville d'Avray, FR)
Assignee: Wyeth LLC (Madison, NJ)
Application Number:12/534,895
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,669,273

Introduction

Patents are a crucial component of intellectual property law, providing inventors and innovators with exclusive rights to their inventions. The United States Patent 8,669,273, like any other patent, has a specific scope and set of claims that define its boundaries and protections. Here, we will delve into the details of this patent, exploring its claims, the patent landscape, and relevant legal and procedural aspects.

What is a Patent?

Before diving into the specifics of U.S. Patent 8,669,273, it is essential to understand what a patent is. A patent is a grant of rights issued by a government to an inventor for a limited time, usually 20 years from the filing date, in exchange for the public disclosure of the invention. The U.S. Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks[2].

Patent 8,669,273 Overview

To analyze the scope and claims of U.S. Patent 8,669,273, one must first identify the patent's title, inventors, assignees, and the date it was granted. Here is a general outline:

  • Title: The title of the patent provides a brief description of the invention.
  • Inventors: The individuals who created the invention.
  • Assignees: The entities to which the patent rights have been assigned.
  • Grant Date: The date when the patent was officially granted.

Claims of the Patent

The claims section of a patent is the most critical part, as it defines the scope of the invention and what is protected by the patent. Claims are typically divided into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims.

For U.S. Patent 8,669,273, one would need to review the patent document to identify the specific claims, their dependencies, and the detailed descriptions provided in the specification.

Specification and Description

The specification and description sections provide a detailed explanation of the invention, including drawings and diagrams. This part helps in understanding how the invention works and its various components.

Patent Landscape

The patent landscape refers to the broader context of related patents and intellectual property in the same field. Here are some key points to consider:

  • Prior Art: The existing body of knowledge in the field that the patent must differentiate itself from to be considered novel and non-obvious.
  • Related Patents: Other patents that may be similar or related to U.S. Patent 8,669,273, which can help in understanding the competitive landscape.
  • Litigation History: Any legal challenges or disputes related to the patent, which can provide insights into its validity and enforceability.

Legal and Procedural Aspects

Patent litigation and the legal framework surrounding patents are crucial for understanding the full scope of a patent.

  • Leahy-Smith America Invents Act (AIA): This act introduced significant changes to the U.S. patent system, including new procedures for challenging patents, such as inter partes review (IPR)[1].
  • Patent Trial and Appeal Board (PTAB): This board within the USPTO handles IPRs and other post-grant review proceedings, which can affect the validity of a patent[5].

Searching and Analyzing Patents

To conduct a thorough analysis of U.S. Patent 8,669,273, one can use various tools and databases:

  • USPTO Databases: The USPTO provides several databases, including the Patent Public Search, which allows for full-text searching of patent grants and applications[4].
  • Patent Claims Research Dataset: This dataset from the USPTO contains detailed information on claims from U.S. patents and can be used to analyze patent scope and claims[3].

Example: Analyzing Claims

Let's consider a hypothetical example of how to analyze the claims of U.S. Patent 8,669,273:

  • Claim 1: "A method for [brief description], comprising [key steps or components]."
    • This claim would be analyzed to understand what specific aspects of the method are protected.
  • Dependent Claim 2: "The method of claim 1, further comprising [additional steps or components]."
    • This claim would be analyzed to see how it narrows down the scope of the independent claim.

Impact of Patent Litigation

Patent litigation can significantly impact the scope and claims of a patent. For instance:

  • Increase in Lawsuits: The number of patent infringement lawsuits can increase due to various factors, such as changes in patent laws or the anticipation of such changes, as seen with the Leahy-Smith America Invents Act (AIA)[1].
  • Inter Partes Review (IPR): IPR proceedings can challenge the validity of patent claims, as seen in cases like Regents of the University of Minnesota v. Gilead Sciences, Inc.[5].

Key Takeaways

  • Patent Claims: The claims section is the most critical part of a patent, defining what is protected.
  • Patent Landscape: Understanding related patents and prior art is essential for assessing the novelty and non-obviousness of an invention.
  • Legal Framework: Changes in patent laws and litigation can affect the validity and scope of a patent.
  • Tools and Databases: Utilizing USPTO databases and other tools can facilitate a thorough analysis of patents.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The primary purpose of the claims section is to define the scope of the invention and specify what is protected by the patent.

Q: How does the Leahy-Smith America Invents Act (AIA) impact patent litigation? A: The AIA introduced new procedures for challenging patents, such as inter partes review (IPR), and limited the number of defendants in a lawsuit, which can increase the number of lawsuits filed.

Q: What is the role of the Patent Trial and Appeal Board (PTAB)? A: The PTAB handles post-grant review proceedings, including IPRs, to determine the validity of patent claims.

Q: How can one search and analyze patents effectively? A: Using databases like the USPTO's Patent Public Search and the Patent Claims Research Dataset can help in conducting a thorough analysis of patents.

Q: Why is understanding the patent landscape important? A: Understanding the patent landscape helps in identifying related patents, prior art, and potential legal challenges, which are crucial for assessing the validity and scope of a patent.

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation[1].
  2. USPTO Website: U.S. Patent and Trademark Office[2].
  3. USPTO Dataset: Patent Claims Research Dataset[3].
  4. Clemson University Guide: Advanced Patent Searching[4].
  5. CAFC Opinion: Regents of the University of Minnesota v. Gilead Sciences, Inc.[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,669,273

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Puma Biotech NERLYNX neratinib maleate TABLET;ORAL 208051-001 Jul 17, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe USE IN COMBINATION WITH CAPECITABINE, FOR THE TREATMENT OF ADULT PATIENTS WITH ADVANCED OR METASTATIC HER2-POSITIVE BREAST CANCER WHO HAVE RECEIVED TWO OR MORE PRIOR ANTI-HER2 BASED REGIMENS IN THE METASTATIC SETTING ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.